Weijia Zhang, PhD
img_Weijia Zhang
PROFESSOR | Medicine, Nephrology

Dr. Zhang is a Co-investigator of the NHGRI-funded U01 grant ‘Biorepositories for Genomic Medicine in Diverse Communities’, and is responsible for SNP and sequencing data analysis for  projects of the National Human Genome Research Institute's ‘Electronic Medical Records and Genomics’ (eMERGE) II Network at MSSM.  He is also a subcontract site - Principal Investigator of several National Institutes of Health funded projects including ' The Pathogenesis of HIV-Associated Nephropathy', ' Targeting Renal Inflammatory Pathways of SLE Nephritis in Mouse and Man' and ' DIaT as a transcriptional regulator of non-replicating Mycobacterium tuberculosis'.  

Research Interests:
  • Integrative analysis of candidate SNPs from genome-wide association analysis study of human complex diseases
  • Algorithm and pipeline development of deep-sequencing analysis
  • Genomics aberration study in cancer and hematological malignancies

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Zhang has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.